Near-Infrared Light Exposure Triggers ROS to Downregulate Inflammatory Cytokines Induced by SARS-CoV-2 Spike Protein in Human Cell Culture
Authors:
- Blanche AguidaBABlanche Aguida
- Marie-Marthe ChabiMCMarie-Marthe Chabi
- Soria BaouzSBSoria Baouz
- Rhys MouldRMRhys Mould
- Jimmy D. BellJimmy D. Bell
- Marootpong PooamMPMarootpong Pooam
- Sebastien AndréSASebastien André
- Dominique ArchambaultDADominique Archambault
- Margaret AhmadMAMargaret Ahmad
- Nathalie JourdanNJNathalie Jourdan
Open Access
- 2 October 2023
- journal article
- research article
- Published by MDPI AG in Antioxidants
- Vol. 12 (10) , 1824
Abstract
The leading cause of mortality from SARS-CoV-2 is an exaggerated host immune response, triggering cytokine storms, multiple organ failure and death. Current drug- and vaccine-based therapies are of limited efficacy against novel viral variants. Infrared therapy is a non-invasive and safe method that has proven effective against inflammatory conditions for over 100 years. However, its mechanism of action is poorly understood and has not received widespread acceptance. We herein investigate whether near-infrared (NIR) light exposure in human primary alveolar and macrophage cells could downregulate inflammatory cytokines triggered by the SARS-CoV-2 spike (S) protein or lipopolysaccharide (LPS), and via what underlying mechanism. Our results showed a dramatic reduction in pro-inflammatory cytokines within days of NIR light treatment, while anti-inflammatory cytokines were upregulated. Mechanistically, NIR light stimulated mitochondrial metabolism, induced transient bursts in reactive oxygen species (ROS) and activated antioxidant gene transcription. These, in turn, downregulated ROS and inflammatory cytokines. A causal relationship was shown between the induction of cellular ROS by NIR light exposure and the downregulation of inflammatory cytokines triggered by SARS-CoV-2 S. If confirmed by clinical trials, this method would provide an immediate defense against novel SARS-CoV-2 variants and other inflammatory infectious diseases.Keywords
Funding Information
- Novo Nordisk Fonden (NNF20OC0061440, 001)
- Guy Foundation (NNF20OC0061440, 001)
This publication has 71 references indexed in Scilit:
- Concentration-dependent Dual Effects of Hydrogen Peroxide on Insulin Signal Transduction in H4IIEC HepatocytesPLOS ONE, 2011
- TLR signalling augments macrophage bactericidal activity through mitochondrial ROSNature, 2011
- Linking oxidative stress to inflammation: Toll-like receptorsFree Radical Biology and Medicine, 2010
- Absorption measurements of a cell monolayer relevant to phototherapy: Reduction of cytochrome c oxidase under near IR radiationJournal of Photochemistry and Photobiology B: Biology, 2005
- Photobiomodulation Directly Benefits Primary Neurons Functionally Inactivated by ToxinsJournal of Biological Chemistry, 2005
- Identification of a Novel Coronavirus in Patients with Severe Acute Respiratory SyndromeNew England Journal of Medicine, 2003
- Defining hormesisHuman & Experimental Toxicology, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Identification of Toll-like receptor 4 (Tlr4) as the sole conduit for LPS signal transduction: genetic and evolutionary studiesInnate Immunity, 2001
- Irradiation with HeNe laser increases ATP level in cells cultivated in vitroJournal of Photochemistry and Photobiology B: Biology, 1995